Skip to main content
Premium Trial:

Request an Annual Quote

Scienion Adds Czech Firm BioVendor to Growing List of Immunoassay Manufacturing Clients

Premium

German array company Scienion recently announced that BioVendor, a provider of medical equipment and research products, is using Scienion's instruments to develop and manufacture in vitro diagnostic and research-use immunoassays, as well as antibodies and recombinant proteins.

CEO Holger Eickhoff told BioArray News this week that BioVendor, based in Brno, Czech Republic, is the latest Scienion customer to announce its adoption of the German firm's tools for manufacturing immunoassays. Other companies that have publicly discussed their relationship with Scienion include Toronto-based SQI Diagnostics, Maine Manufacturing, and Genalyte, he said.

According to Eickhoff, BioVendor is using a number of Scienion products in its manufacturing process, including its SciFlexarrayer dispensers, SciPlex microtiter plates, and SciReader CL for detection of assay results, according to Scienion.

He said that BioVendor's SciFlexarrayers are configured with the Berlin-based company's SciDrop Pico and Nano capabilities. Pico delivers between 50 and 800 picoliters per droplet, while Nano enables the delivery of between eight and 200 nanoliters per droplet, he said. Both offer Scienion customers "an increased range in liquid handling and feature sizes of spots and lines," Eickhoff noted.

BioVendor CEO Viktor Růžička said in a statement that the company is using Scienion's tools to develop new multiplex tests in microtiter plates. Among the IVDs in development is a test for Borrelia infections.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.